Lexicon Q2 2026: $31.8M Loss, SONATA-HCM Enrollment Complete, ZYNQUISTA Resubmission on Track
LXRX sits 91% above its 52-week low of $1.02.
Summary
Lexicon's Q2 2026 loss widened to $31.8M, but the company completed enrollment in its pivotal SONATA-HCM study and expects ZYNQUISTA NDA resubmission in Q4 2026. A new $100M loan facility bolsters cash.
Key Events · Earnings and Guidance · LXRX
-
Q2 2026 Net Loss of $31.8M
Net loss of $31.8 million, or $0.07 per share, compared to net income of $3.3 million in Q2 2025, driven by absence of prior-year licensing revenue and higher R&D costs.
-
SONATA-HCM Enrollment Complete
Pivotal Phase 3 SONATA-HCM study in hypertrophic cardiomyopathy fully enrolled, exceeding 500-patient target; top-line data expected Q1 2027.
-
ZYNQUISTA NDA Resubmission Q4 2026
Resubmission of New Drug Application for ZYNQUISTA in type 1 diabetes anticipated in Q4 2026, supported by ongoing STENO1 safety data.
-
Hercules Capital $100M Loan Facility
Entered $100 million loan facility in May 2026; $55 million initial tranche funded and used to repay prior Oxford Finance loan.
Analysis · LXRX · Life Sciences
A swing from a $3.3 million profit a year ago to a $31.8 million net loss in Q2 2026 underscores the impact of evaporating licensing revenue and rising R&D costs. Yet the quarter also delivered a critical catalyst: enrollment in the pivotal SONATA-HCM trial finished ahead of schedule, with top-line data now expected in Q1 2027—a milestone that could reshape the outlook for a stock trading near $2. Meanwhile, the ZYNQUISTA NDA resubmission is on track for Q4 2026, and a new $100 million loan facility with Hercules Capital extends the financial runway, though the $190.6 million cash balance and ongoing losses keep capital needs firmly in focus.
At the time of this filing, LXRX was trading at $1.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $1.02 to $2.68. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.